Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer Center

BACKGROUND: Poor-risk advanced Renal cell carcinoma (RCC) are an under-evaluated and difficult to treat subset of patients with poor prognosis. While Temsirolimus is the approved first line therapy for this category, Tyrosine kinase inhibitors (TKIs) are also commonly uses as initial treatment. We p...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Indian J Med Paediatr Oncol
Main Authors: Ramaswamy, Anant, Joshi, Amit, Noronha, Vanita, Patil, Vijay, Sahu, Arvind, Manickam, Deepan R, Kothari, Rushabh, Sable, Nilesh, Agrawal, Archi, Menon, Santosh, Prabhash, Kumar
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications & Media Pvt Ltd 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686973/
https://ncbi.nlm.nih.gov/pubmed/29200680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmpo.ijmpo_154_16
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker